Delivery Order SPE2DB22D3016-SPE2DB25FANS4

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is for the delivery of Naloxone HCL 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,792.59 and a completion date of March 14, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of Naloxone HCL 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,249.61 and an ultimate completion date of September 28, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,560,559,581 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The contract, valued at $3,045.39, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 12, 2023. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of 4,563,744,164 units of Naloxone HCL 4 mg Nasal Spray to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $5,364.40 and a completion date of February 23, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. This award is placed under an indefinite delivery contract (IDC) with a...
This federal contract award is for the delivery of 4,558,909,494 units of Naloxone HCL 4 mg Nasal Spray 2's, procured by the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 27, 2022 with a ceiling value of $17,371.69. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This federal contract award is for the delivery of Naloxone HCL 4 mg nasal spray to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $8,554.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of May 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
This federal contract award, valued at $1,405.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of 4,567,316,980 units of 4 mg naloxone HCl nasal spray. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award is for the delivery of Naloxone HCL 4 mg Nasal Spray to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award, valued at $5,359.08, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Naloxone HCL 4 mg Nasal Spray. The award, valued at $1,324.27, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of December 4, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FANS4
    Delivery Order

This contract award is for the supply of Naloxone HCL 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,594.71 and is a delivery order type with a firm fixed price. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award contributes to fulfilling the requirements of that larger IDC.

Generated 5/21/25, 10:08 AM